Vaccine
Safety > Issues of Interest > Thimerosal
References
for
Frequently Asked
Questions
- Ball
L, Ball R, Pratt RD. An assessment of thimerosal
in childhood vaccines. Pediatrics.
2001; 107:1147-1154.
- Forstrom
L, Hannulksela M, Kousa M, Lehmuskallio E.
Merthiolate hypersensitivity and vaccination.
Contact Dermatitis. 1980; 6:241-245.
- Jacobs
RL, Lowe RS, Lanier BQ. Adverse reactions
to tetanus toxoid.
JAMA. 1982; 247:40-41.
- Joint
statement concerning removal of thimerosal
from vaccines. The American Academy of Family
Physicians (AAFP), American Academy of Pediatrics
(AAP), Advisory Committee on Immunization
Practices (ACIP), and United States Public
Health Service (USPHS). Approved June 22,
2000.
- Magos
L. (2000).
Review on the toxicity of ethylmercury,
including its presence as a preservative
in biological and pharmaceutical products.
J. Appl. Toxicol. 2001; 21:1-5.
- Mahaffey
KR.
Methylmercury: A new look at the risks.
Public Health Reports. 1999;
114:397-415.
- Pichichero
ME, Cernichiari E, Lopreiato J, and Treanor
J. Mercury concentrations and metabolism
in infants receiving vaccines containing
thimerosal: a descriptive study. Lancet 360:1737-1741
(2002).
- Toxicological
Profile for Mercury (Update). Agency for
Toxic Substances and Disease Registry, Public
Health Service, US Department of Health and
Human Services. Atlanta, GA, 1999.
Return
to main thimerosal page
|